Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label, Extension Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency

NCT05171855 is registered in ClinicalTrials.gov with Ascendis Pharma Endocrinology Division A/S as lead sponsor.

NCT NCT05171855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05171855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label, Extension Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency
Lead sponsor
Ascendis Pharma Endocrinology Division A/S
Phase
Phase 3
Overall status
Completed
Start date
December 16, 2021
Completion date
December 23, 2024
Enrollment
220 (actual)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

adult growth hormone deficiency, endocrine system diseases, hormone deficiency